Updated on 13 October 2026
Clinical Validation & Co-Development of Synthetic Cohorts in Oncology
Founder at Prodigy AI Solutions
Argenta, Italy
About
1. Project / Cooperation Goal
We are seeking clinical research partners, academic hospitals, and imaging CROs to conduct joint retrospective validation pilots on real-world oncology datasets (specifically NSCLC clinical records and baseline CT scans).Our primary goal is to evaluate and refine CohortForge AI’s generative and reconstruction metrics in a live, clinician-governed environment.
2. What We Bring to the Project (Our Contribution)
-
Deep-Tech Generative AI Studio (TRL 4 MVP): CVAE for clinical table synthesis and 2.5D residual U-Net for CT slice reconstruction.
-
Fail-Closed Governance & Security: Built-in 29-field data crosswalk, subject-level split controls, and aggregate-only exports ensuring data privacy (GDPR compliance).
-
Quantitative Evaluation Harness: Automated scoring for statistical fidelity (KS distance), subgroup balancing, protocol harmonization (kVp), and radiomic biomarker stability (GLCM Joint Entropy).
-
HPC & Cloud Deployment Expertise: Proven experience running GPU workloads on CINECA Leonardo supercomputing infrastructure and NVIDIA Inception ecosystem support.
3. What We Are Seeking from Partners
-
Clinical & Hospital Partners:
-
Data Access: Approved, secure access to retrospective thoracic oncology clinical records and baseline CT scans.
-
Clinical Guidance: Expert input from clinicians and radiologists to define key clinical variables, missingness thresholds, and plausibility criteria.
-
Validation: Independent testing of synthetic data fidelity, missing-field completion, and subgroup balance on held-out patient cohorts.
-
-
EU Consortium Proposals (Horizon Europe / EIT Health / Digital Europe):
- Seeking to join upcoming funding calls as the technology development & data-qualification partner to provide synthetic cohort generation and dataset harmonization.
-
Imaging CROs & MedTech Industry:
- Design-partner collaborations to test protocol-aware harmonization and cohort-qualification workflows for commercial AI pipelines.
Attached files
Similar opportunities
Project cooperation
R84 Consortium: Building Inclusive Cancer Data Partnerships Across Europe
Gizem Yazli
Marketing Lead at PAICON GmbH
Heidelberg, Germany
Project cooperation
- Partner seeks Consortium/Coordinator
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Rosa de Molina
CEO & CTO at Datharsis
Granada, Spain
Project cooperation
- Consortium/Coordinator seeks Partners
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
Dr. Estefanía Ledesma Santiso
CEO at Horizon Europe Leading Projects S.L (HELPEU)
Leon, Spain